Outset Medical, Inc. OM 深 沪
等待开盘 04-01 09:30:00 美东时间
3.84
+0.230
+6.37%
华盛通- 最 高3.84
- 今 开3.65
- 成交量 13.82万股
- 最 低 3.64
- 昨 收 3.61
- 总市值 7031.65万
- 52周最高 21.98
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.00
- 委 比 -72.69%
- 总股本 1831.16万
- 历史最高 978.45
- 量 比 1.15
- 振 幅 5.54%
- 历史最低 3.00
- 每 手 1
- 风险率 5.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | AppLovin评级分歧大！高盛等4家下调，韦德布什上调；HubSpot、休曼纳公司、Shopify、Unity、Paycom Software等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从39美元升至47美元；HC Wainwright & Co.：维持Agios制药"买入"评级，目标价从62美元升至65美元
02-13 15:30
BTIG Maintains Buy on Outset Medical, Lowers Price Target to $15
BTIG analyst Marie Thibault maintains Outset Medical (NASDAQ:OM) with a Buy and lowers the price target from $17 to $15.
02-12 18:01
Outset Medical Sees FY2026 Sales $125.000M-$130.000M vs $127.650M Est
Outset Medical (NASDAQ:OM) sees FY2026 sales of $125.000 million-$130.000 million vs $127.650 million analyst estimate.
02-12 05:04
Outset Medical Q4 Adj. EPS $(0.84) Misses $(0.64) Estimate, Sales $28.874M Beat $26.650M Estimate
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.84) per share which missed the analyst consensus estimate of $(0.64) by 31.87 percent. This is a 84.86 percent increase over losses of $(5.55) per share from
02-12 05:03
Earnings Scheduled For February 11, 2026
Companies Reporting Before The Bell • SiteOne Landscape Supply (NYSE:SITE) is p...
02-11 19:11
Outset Medical Gets FDA's Clearance For Its Tablo Platform
Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the
01-27 22:06
美股牛股 | 私人航空公司UP单日暴涨46%！One Stop大涨29%，获美军预生产订单
私人航空公司UP单日暴涨46%！One Stop股价涨29%，获美军预生产订单；BIOA涨逾27%，核心在研药获突破进展>>
01-13 17:24
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Stifel Maintains Buy on Outset Medical, Lowers Price Target to $8
Stifel analyst Rick Wise maintains Outset Medical (NASDAQ:OM) with a Buy and lowers the price target from $14 to $8.
01-07 22:19
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Outset Medical, Inc. announced that its Chair & CEO, Leslie Trigg, will present at the J.P. Morgan Healthcare conference on January 14, 2026. The presentation will be available live and archived on the company’s investor website. Outset, a medical tech company, has developed the Tablo® Hemodialysis System, FDA-cleared for use from hospitals to homes, reducing the cost and complexity of dialysis. The system is trusted by over 1,000 U.S. healthcare...
01-05 21:05
